Paper37545693
Diagnostic challenges of diabetic kidney disease.
Vučić Lovrenčić M and 2 others. Biochem Med (Zagreb), 2023. Cited by 38 papers, by iCite.
Cite this record
ConductScience Library. Diagnostic challenges of diabetic kidney disease. Papers, record 37545693. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37545693
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Diabetic Nephropathies | Major topic |
| Diabetes Mellitus, Type 2 | Major topic |
| Humans | |
| Cystatin C | |
| Glomerular Filtration Rate | |
| Biomarkers |
Source PubMed
References100
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15111519 | Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. | Diabetes Care | 2004 | https://conductscience.org/library/papers/15111519 | PubMed |
| 2 | 34599655 | Type 1 diabetes in 2017: global estimates of incident and prevalent cases in children and adults. | Diabetologia | 2021 | https://conductscience.org/library/papers/34599655 | PubMed |
| 3 | 29499891 | Measured GFR in Routine Clinical Practice-The Promise of Dried Blood Spots. | Adv Chronic Kidney Dis | 2018 | https://conductscience.org/library/papers/29499891 | PubMed |
| 4 | 35274315 | Metabolomics as a tool for the early diagnosis and prognosis of diabetic kidney disease. | Med Res Rev | 2022 | https://conductscience.org/library/papers/35274315 | PubMed |
| 5 | 35918708 | Pathophysiology of mesangial expansion in diabetic nephropathy: mesangial structure, glomerular biomechanics, and biochemical signaling and regulation. | J Biol Eng | 2022 | https://conductscience.org/library/papers/35918708 | PubMed |
| 6 | 36069913 | What should European nephrology do with the new CKD-EPI equation? | Nephrol Dial Transplant | 2023 | https://conductscience.org/library/papers/36069913 | PubMed |
| 7 | 36514729 | Advantages, Limitations, and Clinical Considerations in Using Cystatin C to Estimate GFR. | Kidney360 | 2022 | https://conductscience.org/library/papers/36514729 | PubMed |
| 8 | 28840540 | A more tubulocentric view of diabetic kidney disease. | J Nephrol | 2017 | https://conductscience.org/library/papers/28840540 | PubMed |
| 9 | 33123356 | The genetic map of diabetic nephropathy: evidence from a systematic review and meta-analysis of genetic association studies. | Clin Kidney J | 2020 | https://conductscience.org/library/papers/33123356 | PubMed |
| 10 | 6283552 | Human gamma-trace, a basic microprotein: amino acid sequence and presence in the adenohypophysis. | Proc Natl Acad Sci U S A | 1982 | https://conductscience.org/library/papers/6283552 | PubMed |
| 11 | 31398309 | An investigation of enzymatic creatinine interference in a patient receiving dopamine and dobutamine. | Clin Biochem | 2019 | https://conductscience.org/library/papers/31398309 | PubMed |
| 12 | 23067652 | KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update. | Am J Kidney Dis | 2012 | https://conductscience.org/library/papers/23067652 | PubMed |
| 13 | 25057786 | Multiplexed LC-MS/MS assay for urine albumin. | J Proteome Res | 2014 | https://conductscience.org/library/papers/25057786 | PubMed |
| 14 | 27507891 | Urinary proteomics predict onset of microalbuminuria in normoalbuminuric type 2 diabetic patients, a sub-study of the DIRECT-Protect 2 study. | Nephrol Dial Transplant | 2017 | https://conductscience.org/library/papers/27507891 | PubMed |
| 15 | 29520581 | Biomarkers of diabetic kidney disease. | Diabetologia | 2018 | https://conductscience.org/library/papers/29520581 | PubMed |
| 16 | 28572883 | Impact of creatinine methodology on glomerular filtration rate estimation in diabetes. | World J Diabetes | 2017 | https://conductscience.org/library/papers/28572883 | PubMed |
| 17 | 31506348 | The single-cell transcriptomic landscape of early human diabetic nephropathy. | Proc Natl Acad Sci U S A | 2019 | https://conductscience.org/library/papers/31506348 | PubMed |
| 18 | 25943757 | Non-proteinuric pathways in loss of renal function in patients with type 2 diabetes. | Lancet Diabetes Endocrinol | 2015 | https://conductscience.org/library/papers/25943757 | PubMed |
| 19 | 25784666 | Kidney injury molecule-1 and the loss of kidney function in diabetic nephropathy: a likely causal link in patients with type 1 diabetes. | Diabetes Care | 2015 | https://conductscience.org/library/papers/25784666 | PubMed |
| 20 | 33859992 | Update on the Mechanisms of Tubular Cell Injury in Diabetic Kidney Disease. | Front Med (Lausanne) | 2021 | https://conductscience.org/library/papers/33859992 | PubMed |
Cited by29
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 38 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42923248 | Renin-Angiotensin System (RAS) Inhibitors in High-Risk Patients With Type 2 Diabetes and Cardio-Renal Risk. | Cureus | 2026 | https://conductscience.org/library/papers/42923248 | PubMed |
| 42770050 | Development and External Validation of a Clinically Applicable Model for Identifying Diabetic Kidney Disease in Population-Based and Clinical Cohorts. | Int J Gen Med | 2026 | https://conductscience.org/library/papers/42770050 | PubMed |
| 42453508 | Development and validation of a predictive model for diabetic kidney disease risk in patients with T2DM: a hospital data platform study. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/42453508 | PubMed |
| 42227359 | Renal Biomarkers as Predictors of Renal Damage in Patients With Type 2 Diabetes. | Biomed Res Int | 2026 | https://conductscience.org/library/papers/42227359 | PubMed |
| 42169644 | Identification of diagnostic markers for diabetic kidney disease by weighted gene co‑expression network analysis and machine learning. | Int J Mol Med | 2026 | https://conductscience.org/library/papers/42169644 | PubMed |
| 42158326 | Animal models for diabetic kidney disease: perspectives and prospects. | Front Vet Sci | 2026 | https://conductscience.org/library/papers/42158326 | PubMed |
| 42100196 | Integration of digital physicalomics and dual-fluid metabolomics flux ratios reveals tubular secretory dysfunction in early diabetic kidney disease. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/42100196 | PubMed |
| 42028288 | Clinical Utility of Urinary Cystatin C in Early Screening and Staging of Diabetic Kidney Disease in Type 2 Diabetes. | Int J Endocrinol | 2026 | https://conductscience.org/library/papers/42028288 | PubMed |
| 41986538 | Development and validation of an early risk prediction model based on inflammatory and metabolically derived markers for early diagnosis of diabetic kidney disease. | Sci Rep | 2026 | https://conductscience.org/library/papers/41986538 | PubMed |
| 41685791 | Feasibility of Integrating Urinary Proteomics and Machine Learning for Diagnosing Diabetic Nephropathy. | J Proteome Res | 2026 | https://conductscience.org/library/papers/41685791 | PubMed |
| 41605139 | Optimizing Early Detection of Diabetic Kidney Disease through Synergistic Biomarkers and Serum Metabolites in Humans. | Diabetes Metab J | 2026 | https://conductscience.org/library/papers/41605139 | PubMed |
| 41596641 | Metabolomics for Preclinical Detection of Diabetic Kidney Disease: A Comprehensive Review. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41596641 | PubMed |
| 41541753 | The Role and Clinical Significance of miR-484 in the Regulation of SGLT2 in Diabetic Nephropathy. | Int J Endocrinol | 2026 | https://conductscience.org/library/papers/41541753 | PubMed |
| 41171478 | Reliable biomarkers for diabetic nephropathy using machine learning-assisted contrast-enhanced ultrasonography and clinical characteristics. | Clin Exp Med | 2025 | https://conductscience.org/library/papers/41171478 | PubMed |
| 40746620 | The multifunctional role of bovine colostrum in managing diabetes: clinical insights and potential therapeutic effects. | J Diabetes Metab Disord | 2025 | https://conductscience.org/library/papers/40746620 | PubMed |
| 40721630 | Associations between serum JAML, nesfatin-1, and 25(OH)D and the risk of diabetic kidney disease in patients with type 2 diabetes. | Sci Rep | 2025 | https://conductscience.org/library/papers/40721630 | PubMed |
| 40538805 | Renal microcirculation and mechanisms in diabetic kidney disease. | Front Endocrinol (Lausanne) | 2025 | https://conductscience.org/library/papers/40538805 | PubMed |
| 40331155 | Preliminary insight into the potential role of Leptin Receptor Polymorphisms in Type 2 Diabetes Risk: case-control study and bioinformatics analysis. | J Diabetes Metab Disord | 2025 | https://conductscience.org/library/papers/40331155 | PubMed |
| 40291021 | Diagnostic value of serum TGF-β1 and CysC in type 2 diabetic kidney disease: a cross-sectional study. | Front Med (Lausanne) | 2025 | https://conductscience.org/library/papers/40291021 | PubMed |
| 40216906 | The application value of multimodal ultrasound imaging technology in the prediction of early-stage type 2 diabetic kidney disease. | Sci Rep | 2025 | https://conductscience.org/library/papers/40216906 | PubMed |
Genes21
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37545693
GET https://conductscience.org/api/papers/v1/37545693/references?page=2